Human T-Lymphotropic Virus Type 1 p30 II Functions as a Transcription Factor and Differentially Modulates CREB-Responsive Promoters
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Human T-lymphotropic virus type 1 (HTLV-1), a complex retrovirus, causes adult T-cell lymphoma/leukemia and is linked to a variety of immune-mediated disorders. The roles of proteins encoded in the pX open reading frame (ORF) II gene region in HTLV-1 replication or in mediating virus-associated diseases remain to be defined. A nucleus-localizing 30-kDa protein, p30 II , encoded within pX ORF II has limited homology with the POU family of transcription factors. Recently, we reported that selected mutations in pX ORF II diminish the ability of HTLV-1 to maintain high viral loads in infected rabbits. Herein we have tested the transcriptional ability of p30 II in mammalian cells by using yeast Gal4 fusion protein vectors and transfection of luciferase reporter genes driven by CREB-responsive promoters. p30 II as a Gal4 DNA-binding domain (DBD) fusion protein transactivates Gal4-driven luciferase reporter gene activity up to 25-fold in 293 and HeLa-tat cells. We confirmed nuclear localization of p30 II and demonstrate dose-dependent binding of p30 II -Gal4(DBD) to Gal4 DNA-binding sites. The transcriptional activity of p30 II -Gal4(DBD) was independent of TATA box flanking sequences, as shown by using two different Gal4 reporter systems. Studies of selected p30 II mutants indicated that domains that mediate transcription are restricted to a central core region of the protein between amino acids 62 and 220. Transfection of a p30 II -expressing plasmid repressed cellular CRE-driven reporter gene activity, with or without Tax expression. In contrast, p30 II at lower concentrations enhanced HTLV-1 long terminal repeat-driven reporter gene activity independent of Tax expression. These data are the first to demonstrate a transcriptional function for p30 II and suggest a mechanism by which this nuclear protein may influence HTLV-1 replication or cellular gene expression in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7415 · Cited by 5,043 · cited 8×
“Similarly, all truncated mutants (MT-1 through MT-6) of the p30II expression vector were constructed by replacing CREB-(1-247)-encoding sequence of CREBGal4-pCRG4-11 (containing Gal4-DBD) with appropriate truncated p30II-encoding sequences synthesized by PCR from ACH using the following primers: for MT-1, p30II(1-220)…”
MethodInfluentialYoshida, M., Miyoshi, I., & Hinuma, Y. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.6.2031 · Cited by 2,169 · cited 8×
“Similarly, all truncated mutants (MT-1 through MT-6) of the p30II expression vector were constructed by replacing CREB-(1-247)-encoding sequence of CREBGal4-pCRG4-11 (containing Gal4-DBD) with appropriate truncated p30II-encoding sequences synthesized by PCR from ACH using the following primers: for MT-1, p30II(1-220)…”
MethodInfluentialBerneman, Z. N., Gartenhaus, R. B., Reitz, M. S., Blattner, W. A., Manns, A., Hanchard, B., Ikehara, O., Gallo, R. C., & Klotman, M. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3005 · Cited by 151 · cited 3×
“At least eight alternatively spliced mRNAs are expressed from the 39 or pX region of HTLV-1 (2).”
BackgroundMethod
Cited by
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Matsuoka, M., & Jeang, K.-T. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2111 · Cited by 829
Arnold, J., Yamamoto, B., Li, M., Phipps, A. J., Younis, I., Lairmore, M. D., & Green, P. L. (2006) · Blood · doi:10.1182/blood-2005-11-4551 · Cited by 196
Self-citationHuman T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Kannian, P., & Green, P. L. (2010) · Viruses · doi:10.3390/v2092037 · Cited by 139
Metadata
- Authors
- Zhang, W., Nisbet, J. W., Bartoe, J. T., Ding, W., & Lairmore, M. D.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2000-12
- Volume
- 74
- Issue
- 23
- Pages
- 11270-11277
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2118433514
- Cited by
- 84
- References
- 3
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Human T-Lymphotropic Virus Type 1 p30 II Functions as a Transcription Factor and Differentially Modulates CREB-Responsive Promoters. https://app.cochat.ai/papers/10.1128/jvi.74.23.11270-11277.2000
- The paper
- Zhang, W., Nisbet, J. W., Bartoe, J. T., Ding, W., & Lairmore, M. D. (2000). Human T-Lymphotropic Virus Type 1 p30 II Functions as a Transcription Factor and Differentially Modulates CREB-Responsive Promoters. Journal of Virology. https://doi.org/10.1128/jvi.74.23.11270-11277.2000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.